Neuroprogression: the hidden mechanism of depression
Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatrí...
Ausführliche Beschreibung
Autor*in: |
Labra Ruiz NA [verfasserIn] Santamaría del Ángel D [verfasserIn] Juárez Olguín H [verfasserIn] Lindoro Silva M [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2018 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Neuropsychiatric Disease and Treatment - Dove Medical Press, 2009, (2018), Seite 2837-2845 |
---|---|
Übergeordnetes Werk: |
year:2018 ; pages:2837-2845 |
Links: |
---|
Katalog-ID: |
DOAJ076747891 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ076747891 | ||
003 | DE-627 | ||
005 | 20230503001044.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2018 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ076747891 | ||
035 | |a (DE-599)DOAJ50a8c775823a4144a3092eeffc86a539 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC321-571 | |
050 | 0 | |a RC346-429 | |
100 | 0 | |a Labra Ruiz NA |e verfasserin |4 aut | |
245 | 1 | 0 | |a Neuroprogression: the hidden mechanism of depression |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine | ||
650 | 4 | |a Depressive disorder | |
650 | 4 | |a monoamines | |
650 | 4 | |a neuroprogression | |
650 | 4 | |a neuroendocrine | |
653 | 0 | |a Neurosciences. Biological psychiatry. Neuropsychiatry | |
653 | 0 | |a Neurology. Diseases of the nervous system | |
700 | 0 | |a Santamaría del Ángel D |e verfasserin |4 aut | |
700 | 0 | |a Juárez Olguín H |e verfasserin |4 aut | |
700 | 0 | |a Lindoro Silva M |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Neuropsychiatric Disease and Treatment |d Dove Medical Press, 2009 |g (2018), Seite 2837-2845 |w (DE-627)481905693 |w (DE-600)2180554-4 |x 11782021 |7 nnns |
773 | 1 | 8 | |g year:2018 |g pages:2837-2845 |
856 | 4 | 0 | |u https://doaj.org/article/50a8c775823a4144a3092eeffc86a539 |z kostenfrei |
856 | 4 | 0 | |u https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1178-2021 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |j 2018 |h 2837-2845 |
author_variant |
l r n lrn s d á d sdád j o h joh l s m lsm |
---|---|
matchkey_str |
article:11782021:2018----::erporsinhhdemcai |
hierarchy_sort_str |
2018 |
callnumber-subject-code |
RC |
publishDate |
2018 |
allfields |
(DE-627)DOAJ076747891 (DE-599)DOAJ50a8c775823a4144a3092eeffc86a539 DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Labra Ruiz NA verfasserin aut Neuroprogression: the hidden mechanism of depression 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine Depressive disorder monoamines neuroprogression neuroendocrine Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Santamaría del Ángel D verfasserin aut Juárez Olguín H verfasserin aut Lindoro Silva M verfasserin aut In Neuropsychiatric Disease and Treatment Dove Medical Press, 2009 (2018), Seite 2837-2845 (DE-627)481905693 (DE-600)2180554-4 11782021 nnns year:2018 pages:2837-2845 https://doaj.org/article/50a8c775823a4144a3092eeffc86a539 kostenfrei https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT kostenfrei https://doaj.org/toc/1178-2021 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2018 2837-2845 |
spelling |
(DE-627)DOAJ076747891 (DE-599)DOAJ50a8c775823a4144a3092eeffc86a539 DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Labra Ruiz NA verfasserin aut Neuroprogression: the hidden mechanism of depression 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine Depressive disorder monoamines neuroprogression neuroendocrine Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Santamaría del Ángel D verfasserin aut Juárez Olguín H verfasserin aut Lindoro Silva M verfasserin aut In Neuropsychiatric Disease and Treatment Dove Medical Press, 2009 (2018), Seite 2837-2845 (DE-627)481905693 (DE-600)2180554-4 11782021 nnns year:2018 pages:2837-2845 https://doaj.org/article/50a8c775823a4144a3092eeffc86a539 kostenfrei https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT kostenfrei https://doaj.org/toc/1178-2021 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2018 2837-2845 |
allfields_unstemmed |
(DE-627)DOAJ076747891 (DE-599)DOAJ50a8c775823a4144a3092eeffc86a539 DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Labra Ruiz NA verfasserin aut Neuroprogression: the hidden mechanism of depression 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine Depressive disorder monoamines neuroprogression neuroendocrine Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Santamaría del Ángel D verfasserin aut Juárez Olguín H verfasserin aut Lindoro Silva M verfasserin aut In Neuropsychiatric Disease and Treatment Dove Medical Press, 2009 (2018), Seite 2837-2845 (DE-627)481905693 (DE-600)2180554-4 11782021 nnns year:2018 pages:2837-2845 https://doaj.org/article/50a8c775823a4144a3092eeffc86a539 kostenfrei https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT kostenfrei https://doaj.org/toc/1178-2021 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2018 2837-2845 |
allfieldsGer |
(DE-627)DOAJ076747891 (DE-599)DOAJ50a8c775823a4144a3092eeffc86a539 DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Labra Ruiz NA verfasserin aut Neuroprogression: the hidden mechanism of depression 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine Depressive disorder monoamines neuroprogression neuroendocrine Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Santamaría del Ángel D verfasserin aut Juárez Olguín H verfasserin aut Lindoro Silva M verfasserin aut In Neuropsychiatric Disease and Treatment Dove Medical Press, 2009 (2018), Seite 2837-2845 (DE-627)481905693 (DE-600)2180554-4 11782021 nnns year:2018 pages:2837-2845 https://doaj.org/article/50a8c775823a4144a3092eeffc86a539 kostenfrei https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT kostenfrei https://doaj.org/toc/1178-2021 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2018 2837-2845 |
allfieldsSound |
(DE-627)DOAJ076747891 (DE-599)DOAJ50a8c775823a4144a3092eeffc86a539 DE-627 ger DE-627 rakwb eng RC321-571 RC346-429 Labra Ruiz NA verfasserin aut Neuroprogression: the hidden mechanism of depression 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine Depressive disorder monoamines neuroprogression neuroendocrine Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system Santamaría del Ángel D verfasserin aut Juárez Olguín H verfasserin aut Lindoro Silva M verfasserin aut In Neuropsychiatric Disease and Treatment Dove Medical Press, 2009 (2018), Seite 2837-2845 (DE-627)481905693 (DE-600)2180554-4 11782021 nnns year:2018 pages:2837-2845 https://doaj.org/article/50a8c775823a4144a3092eeffc86a539 kostenfrei https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT kostenfrei https://doaj.org/toc/1178-2021 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 2018 2837-2845 |
language |
English |
source |
In Neuropsychiatric Disease and Treatment (2018), Seite 2837-2845 year:2018 pages:2837-2845 |
sourceStr |
In Neuropsychiatric Disease and Treatment (2018), Seite 2837-2845 year:2018 pages:2837-2845 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Depressive disorder monoamines neuroprogression neuroendocrine Neurosciences. Biological psychiatry. Neuropsychiatry Neurology. Diseases of the nervous system |
isfreeaccess_bool |
true |
container_title |
Neuropsychiatric Disease and Treatment |
authorswithroles_txt_mv |
Labra Ruiz NA @@aut@@ Santamaría del Ángel D @@aut@@ Juárez Olguín H @@aut@@ Lindoro Silva M @@aut@@ |
publishDateDaySort_date |
2018-01-01T00:00:00Z |
hierarchy_top_id |
481905693 |
id |
DOAJ076747891 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ076747891</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503001044.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ076747891</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ50a8c775823a4144a3092eeffc86a539</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC321-571</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC346-429</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Labra Ruiz NA</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neuroprogression: the hidden mechanism of depression</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Norma A Labra Ruiz,1 Daniel Santamar&iacute;a del &Aacute;ngel,1 Hugo Ju&aacute;rez Olgu&iacute;n,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatr&iacute;a (INP), and Faculty of Medicine, Universidad Nacional Aut&oacute;noma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people&acute;s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Depressive disorder</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">monoamines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">neuroprogression</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">neuroendocrine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neurosciences. Biological psychiatry. Neuropsychiatry</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neurology. Diseases of the nervous system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Santamaría del Ángel D</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Juárez Olguín H</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lindoro Silva M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Neuropsychiatric Disease and Treatment</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2018), Seite 2837-2845</subfield><subfield code="w">(DE-627)481905693</subfield><subfield code="w">(DE-600)2180554-4</subfield><subfield code="x">11782021</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2018</subfield><subfield code="g">pages:2837-2845</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/50a8c775823a4144a3092eeffc86a539</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1178-2021</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2018</subfield><subfield code="h">2837-2845</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Labra Ruiz NA |
spellingShingle |
Labra Ruiz NA misc RC321-571 misc RC346-429 misc Depressive disorder misc monoamines misc neuroprogression misc neuroendocrine misc Neurosciences. Biological psychiatry. Neuropsychiatry misc Neurology. Diseases of the nervous system Neuroprogression: the hidden mechanism of depression |
authorStr |
Labra Ruiz NA |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)481905693 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC321-571 |
illustrated |
Not Illustrated |
issn |
11782021 |
topic_title |
RC321-571 RC346-429 Neuroprogression: the hidden mechanism of depression Depressive disorder monoamines neuroprogression neuroendocrine |
topic |
misc RC321-571 misc RC346-429 misc Depressive disorder misc monoamines misc neuroprogression misc neuroendocrine misc Neurosciences. Biological psychiatry. Neuropsychiatry misc Neurology. Diseases of the nervous system |
topic_unstemmed |
misc RC321-571 misc RC346-429 misc Depressive disorder misc monoamines misc neuroprogression misc neuroendocrine misc Neurosciences. Biological psychiatry. Neuropsychiatry misc Neurology. Diseases of the nervous system |
topic_browse |
misc RC321-571 misc RC346-429 misc Depressive disorder misc monoamines misc neuroprogression misc neuroendocrine misc Neurosciences. Biological psychiatry. Neuropsychiatry misc Neurology. Diseases of the nervous system |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Neuropsychiatric Disease and Treatment |
hierarchy_parent_id |
481905693 |
hierarchy_top_title |
Neuropsychiatric Disease and Treatment |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)481905693 (DE-600)2180554-4 |
title |
Neuroprogression: the hidden mechanism of depression |
ctrlnum |
(DE-627)DOAJ076747891 (DE-599)DOAJ50a8c775823a4144a3092eeffc86a539 |
title_full |
Neuroprogression: the hidden mechanism of depression |
author_sort |
Labra Ruiz NA |
journal |
Neuropsychiatric Disease and Treatment |
journalStr |
Neuropsychiatric Disease and Treatment |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2018 |
contenttype_str_mv |
txt |
container_start_page |
2837 |
author_browse |
Labra Ruiz NA Santamaría del Ángel D Juárez Olguín H Lindoro Silva M |
class |
RC321-571 RC346-429 |
format_se |
Elektronische Aufsätze |
author-letter |
Labra Ruiz NA |
author2-role |
verfasserin |
title_sort |
neuroprogression: the hidden mechanism of depression |
callnumber |
RC321-571 |
title_auth |
Neuroprogression: the hidden mechanism of depression |
abstract |
Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine |
abstractGer |
Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine |
abstract_unstemmed |
Norma A Labra Ruiz,1 Daniel Santamaría del Ángel,1 Hugo Juárez Olguín,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatría (INP), and Faculty of Medicine, Universidad Nacional Autónoma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people´s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
title_short |
Neuroprogression: the hidden mechanism of depression |
url |
https://doaj.org/article/50a8c775823a4144a3092eeffc86a539 https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT https://doaj.org/toc/1178-2021 |
remote_bool |
true |
author2 |
Santamaría del Ángel D Juárez Olguín H Lindoro Silva M |
author2Str |
Santamaría del Ángel D Juárez Olguín H Lindoro Silva M |
ppnlink |
481905693 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
callnumber-a |
RC321-571 |
up_date |
2024-07-03T22:12:00.575Z |
_version_ |
1803597612923748352 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ076747891</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230503001044.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ076747891</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ50a8c775823a4144a3092eeffc86a539</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC321-571</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC346-429</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Labra Ruiz NA</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neuroprogression: the hidden mechanism of depression</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Norma A Labra Ruiz,1 Daniel Santamar&iacute;a del &Aacute;ngel,1 Hugo Ju&aacute;rez Olgu&iacute;n,2 Miroslava Lindoro Silva2 1Laboratory of Neurosciences, Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Pharmacology, Instituto Nacional de Pediatr&iacute;a (INP), and Faculty of Medicine, Universidad Nacional Aut&oacute;noma de Mexico, Mexico City, Mexico Abstract: For many years, depressive disorder (DD) was considered a transient and natural disease of people&acute;s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and observed in the clinical manifestations, biochemical markers, and cerebral structures of the patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders. DD is considered a potentially aggressive state of neuronal deterioration involving apoptosis, reduced neurogenesis, decreased neuronal plasticity, and increased immune response. Clinically, it encompasses a poor response to treatment and an increase in depressive episodes, both of which bring about vulnerability and decline of functions associated with structural changes in the brain. The interest of this work is to review the metabolic processes involved in the morphologic alterations in the limbic system reported in patients with MDD, as well as the neurologic bases of this complex pathology that include environmental stress, genetic vulnerability, alterations in the neurotransmission, and changes in the neuroplasticity, all of which today bring into limelight a mechanism of progressive neuronal damage. Keywords: depressive disorder, monoamines, neuroprogression, neuroendocrine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Depressive disorder</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">monoamines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">neuroprogression</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">neuroendocrine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neurosciences. Biological psychiatry. Neuropsychiatry</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neurology. Diseases of the nervous system</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Santamaría del Ángel D</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Juárez Olguín H</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lindoro Silva M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Neuropsychiatric Disease and Treatment</subfield><subfield code="d">Dove Medical Press, 2009</subfield><subfield code="g">(2018), Seite 2837-2845</subfield><subfield code="w">(DE-627)481905693</subfield><subfield code="w">(DE-600)2180554-4</subfield><subfield code="x">11782021</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2018</subfield><subfield code="g">pages:2837-2845</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/50a8c775823a4144a3092eeffc86a539</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.dovepress.com/neuroprogression-the-hidden-mechanism-of-depression-peer-reviewed-article-NDT</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1178-2021</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2018</subfield><subfield code="h">2837-2845</subfield></datafield></record></collection>
|
score |
7.400055 |